欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

Inflammation/Immunology

货号 产品名 CAS号 信息
CSN21369 Zegocractin 1713240-67-5 CM4620 is a CRAC channel inhibitor to treat acute pancreatitis.
CSN21221 AG126 118409-62-4 AG 126 selectively inhibits the phosphorylation of ERK1 and ERK2 at 25-50 μM.
CSN21243 KI696 1799974-70-1 KI696 is a high affinity probe that disrupts the Keap1/NRF2 interaction.
CSN21303 Kynurenic acid sodium 2439-02-3 Kynurenic acid, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, α7 nicotinic acetylcholine receptor. Kynurenic acid is also a selective ligand of the GPR35 receptor.
CSN21280 GW-870086 827319-43-7 GW-870086 is a glucocorticoid receptor agonist potentially for the treatment of asthma and atopic dermatitis.
CSN21186 Naproxen etemesil 385800-16-8 Naproxen etemesil is a lipophilic, non-acidic, inactive prodrug of naproxen that is hydrolysed to pharmacologically active Naproxen once absorbed. Naproxen is a COX-1 and COX-2 inhibitor with IC50s of 2.2 and 1.3 μg/mL, respectively in cell assay.
CSN21115 3-Deazaadenosine 6736-58-9 3-Deazaadenosine is an inhibitor of S-adenosylhomocysteine hydrolase, with a Ki of 3.9 µM; has anti-inflammatory, anti-proliferative and anti-HIV activity.
CSN21322 Cgs 15435 95853-92-2 CGS 15435, a potent thromboxane (TxA2) synthetase inhibitor with an IC50 of 1 nM, has a selectivity for Tx synthetase 100000-fold greater than that for cyclooxygenase, PGI2 synthetase and lipoxygenase enzymes.
CSN21196 GENZ-882706 2070864-35-4 GENZ-882706 is a potent colony stimulating factor-1 receptor (CSF-1R) inhibitor that intends to treat immune-mediated diseases and neurological diseases.
CSN21292 FR167344 215258-13-2 FR167344 free base is an orally active, nonpeptide bradykinin receptor B2 antagonist. FR167344 free base shows a high affinity binding to the B2 receptor with an IC50value of 65 nM and no binding affinity for the B1 receptor.
CSN21197 ABBV-744 2138861-99-9 ABBV-744 is an inhibitor of BDII-selective BET bromodomain that is being investigated to treat AML and metastic castration-resistant prostate cancer.
CSN21343 Chymase-IN-1 862090-74-2 Chymase-IN-1 is a potent, selective, orally active, nonpeptide inhibitor of human mast cell chymase with an IC50 of 29 nM.
CSN21330 Trifarotene 895542-09-3 Trifarotene is a retinoic acid receptor (RAR) agonist with Kdapp of 2, 15 and 500 nM for RARγ, RARβ and RARα, respectively.
CSN21139 DIM-C-pPhOCH3 33985-68-1 DIM-C-pPhOCH3 is a Nur77 agonist. Nerve growth factor-induced Bα (NGFI-Bα, Nur77) is an orphan nuclear receptor.
CSN21262 CU-CPT9b 2162962-69-6 CU-CPT9a is a selective Toll-like receptor 8 (TLR8) inhibitor with IC50 of 0.5 nM. It can also suppress TNF-α levels.
CSN21128 IPI-3063 1425043-73-7 IPI-3063 is a potent and selective PI3K p110δ inhibitor with an IC50 of 2.5 ± 1.2 nM.
CSN21122 Desisobutyryl-ciclesonide 161115-59-9 Desisobutyryl-ciclesonide is the active metabolite of Ciclesonide. Desisobutyryl-ciclesonide has affinity for the glucocorticoid receptor.
CSN21229 Delgocitinib 1263774-59-9 Delgocitinib is a novel and specific JAK inhibitor with IC50s of 2.8, 2.6, 13 and 58 nM for JAK1, JAK2, JAK3 and Tyk2, respectively.
CSN21234 S-methyl-KE-298 143584-75-2 S-methyl-KE-298 is an active metabolite of KE-298. KE-298 inhibits matrix metalloproteinase (MMP-1) production from rheumatoid arthritis (RA) synovial cells.
CSN21261 CU-CPT-9a 2165340-32-7 CU-CPT9b is a selective inhibitor of TLR8 with IC50 and Kd of 0.7 nM and 21 nM.
CSN21230 CP-96486 139401-45-9 CP-96486 is a potent and orally active leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor antagonist with Kis of 20 and 24 nM, respectively.
CSN21188 NSC117079 500363-63-3 NSC117079 is a PHLPP inhibitor.
CSN21134 Mebhydrolin 524-81-2 Mebhydrolin is a specific histamine H1 receptor antagonist.
CSN21223 AKP-11 1220973-37-4 AKP-11 is a S1P1 agonist with immunomodulatory activities.AKP-11 (1.3mg/kg) attenuates EAE disease.
CSN21218 CY-09 1073612-91-5 CY-09 can inhibit NLRP3 with Kd value of 500 nM through directly bounding to the ATP-binding site of the NLRP3 NACHT domain.
CSN21301 FR183998 239440-20-1 FR183998 free base is a potent Na+/H+-exchange inhibitor, with IC50s of 0.3 nM, 3.1 nM and 6.5 nM by measurement of pHi change in rat lymphocytes, rat and human platelets, respectively.
CSN21154 (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid 1025967-78-5 Lifitegrast is a novel small molecule integrin antagonist which can inhibit an integrin, lymphocyte function-associated antigen 1 (LFA-1), from binding to intercellular adhesion molecule 1 (ICAM-1).
CSN21112 Licogliflozin 1291094-73-9 Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor
CSN21105 N-Acetylhistamine 673-49-4 N-acetylhistamine is a histamine metabolite. N-acetylhistamine can be used as a potential biomarker of histidine metabolism for anaphylactoid reactions.
CSN21315 Pirolate 55149-05-8 Pirolate (CP-32,387) is an antihistamine drug with a tricyclic chemical structure which was patented as an "antiallergen".
CSN21394 RO1138452 221529-58-4 RO1138452 is a selective antagonist of prostacyclin (IP) receptor with pKi of 9.3 ± 0.1 in human platelets.
CSN21069 ABT-702 2HCl 1188890-28-9 ABT702 2HCl is a potent non-nucleoside adenosine kinase inhibitor with IC50 value of 1.7 nM, displaying oral activity in animal models of pain and inflammation.
CSN20558 CYM5442 1094042-01-9 CYM-5442 is a highly-selective S1P1 (Spingosine 1-Phosphate Receptor 1) agonist. CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment.
CSN21072 AB-423 1572510-80-5 AB-423 is Arbutus' first-generation capsid inhibitor, which was generally safe and well tolerated in Phase 1 healthy volunteer studies.
CSN20658 Velsecorat 1196509-60-0 AZD7594 is an inhaled selective glucocorticoid receptor (GCCR) modulator for the treatment of mild to moderate asthma and chronic obstructive pulmonary disorder (COPD).
CSN20665 AZD2098 566203-88-1 AZD2098 is a potent CC-chemokine receptor 4 (CCR4) inhibitor, used for asthma research.
CSN20549 S-(+)-Ketoprofen 22161-81-5 (S)-Ketoprofen is a potent inhibitor of COX with IC50 of 1.9 and 27 nM for COX1 and 2 respectively.
CSN20673 Leniolisib 1354690-24-6 Leniolisib is a potent and selective PI3Kδ inhibitor currently in used for the treatment of immunodeficiency disorders.
CSN20632 Octreotide 83150-76-9 Octreotide is an analog of somatostatin that binds to the somatostatin receptor 2/3/5. It can increase Gi activity and reduce the production of intracellular cAMP.
CSN20674 Mavacoxib 170569-88-7 Mavacoxib is a veterinary drug used to treat pain and inflammation in dogs with degenerative joint disease. It acts as a COX-2 inhibitor.
CSN20611 BI 665915 1360550-04-4 BI 665915 is an oxadiazole-containing 5-lipoxygenase activating protein (FLAP) inhibitor with binding IC50 < 10 nM and LTB4 synthesis IC50 < 100 nM in human whole blood.
CSN20657 AZD5423 1034148-04-3 AZD5423 is a nonsteroidal glucocorticoid receptor agonist.
CSN20666 AZD-1678 942137-41-9 AZD1678 is a potent CC-chemokine receptor 4 (CCR4) inhibitor, used for asthma research.
CSN20566 PL265 1206514-62-6 PL265 is a preclinical, long-acting dual enkephalinase inhibitor (DENKi), with analgesic potential and has been developed as a therapeutic for control of intractable cancer pain.
CSN21103 MRT67307 2HCl 1781882-89-0 MRT67307 HCl is a potent and dual IKKε and TBK1 inhibitor.
CSN21410 H3R antagonist 1 hydrochloride 2319790-07-1 H3R-IN-1 HCl is a histamine receptor 3 (H3R) inverse agonist.
CSN21351 MD2-IN-1 111797-22-9 MD2-IN-1 is an inhibitor of Myeloid differentiation protein 2 (MD2) with a KD of 189  μM for the recombinant human MD2 (rhMD2).
CSN21399 Saikogenin A 5092-09-1 Saikogenin A, extracted from a Chinese herbal plant called Tsai-Fu, is a dipeptidyl peptidase-IV (DPP-IV) inhibitor.
CSN21412 PMX 205 Trifluoroacetate N/A PMX 205 Trifluoroacetate is a potent complement C5a receptor (C5aR; CD88) antagonist.
<< PREV 1 2 3 4 5 6 7 8 9 NEXT >>
联系
我们